In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice.
about
FFA4/GPR120: Pharmacology and Therapeutic Opportunities.Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy.Lowering the n-6/n-3 PUFAs ratio inhibits the formation of THP-1 macrophage-derived foam cell.Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases
P2860
In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
In vivo activation of leukocyt ...... in LDL receptor knockout mice.
@en
In vivo activation of leukocyt ...... in LDL receptor knockout mice.
@nl
type
label
In vivo activation of leukocyt ...... in LDL receptor knockout mice.
@en
In vivo activation of leukocyt ...... in LDL receptor knockout mice.
@nl
prefLabel
In vivo activation of leukocyt ...... in LDL receptor knockout mice.
@en
In vivo activation of leukocyt ...... in LDL receptor knockout mice.
@nl
P2093
P2860
P356
P1476
In vivo activation of leukocyt ...... in LDL receptor knockout mice.
@en
P2093
Amanda L Brown
Elena Boudyguina
Janet K Sawyer
John S Parks
Martha A Alexander-Miller
Swapnil V Shewale
P2860
P304
P356
10.1194/JLR.M072769
P577
2016-11-03T00:00:00Z